Nitto Denko Corporation provided consolidated earnings guidance for the fiscal year ending March 31, 2023. For the fiscal year, the company expected net sales of JPY 700,000 million, operating income of JPY 55,000 million, net income of JPY 46,500 million and basic earnings per share of JPY 158.85.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6,764 JPY | +1.87% | -0.22% | -4.08% |
24/05 | BioArctic, Eisai's Azlheimer’s Disease Drug Wins Regulatory Nod in South Korea | MT |
16/05 | Eisai's Attributable Profit Falls 23.5% in Fiscal 2024 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.08% | 12.36B | |
+38.51% | 727B | |
+33.05% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.09% | 205B | |
-5.77% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- 4523 Stock
- News Eisai Co., Ltd.
- Nitto Denko Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2023